Details for Patent: 9,198,858
✉ Email this page to a colleague
Which drugs does patent 9,198,858 protect, and when does it expire?
Patent 9,198,858 protects NUVESSA and is included in one NDA.
This patent has fifteen patent family members in eight countries.
Summary for Patent: 9,198,858
| Title: | Methods of treating bacterial vaginosis with aqueous-based metronidazole gel formulations |
| Abstract: | The present disclosure provides mucoadhesive aqueous-based gel formulations of metronidazole useful for a variety of purposes, including intravaginal application as a therapeutic approach towards the treatment of individuals suffering from and/or diagnosed with bacterial vaginosis. |
| Inventor(s): | Michael T. Nordsiek, Kodumudi S. Balaji |
| Assignee: | Chemo Research SL , Allergan Finance LLC |
| Application Number: | US13/593,386 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,198,858 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
| Patent landscape, scope, and claims: |
More… ↓ |
Drugs Protected by US Patent 9,198,858
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alembic Therap | NUVESSA | metronidazole | GEL;VAGINAL | 205223-001 | Mar 24, 2014 | RX | Yes | Yes | 9,198,858 | ⤷ Start Trial | TREATMENT OF BACTERIAL VAGINOSIS WITH METRONIDAZOLE GEL | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,198,858
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2012275292 | ⤷ Start Trial | |||
| Australia | 2016200825 | ⤷ Start Trial | |||
| Brazil | 112013033759 | ⤷ Start Trial | |||
| Canada | 2840571 | ⤷ Start Trial | |||
| Canada | 3054236 | ⤷ Start Trial | |||
| China | 103763925 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
